Pfizer-BioNTech COVID shot 73.2 per cent effective in kids aged under five years, reveals new data
The updated data released yesterday showed 13 children had COVID-19, at least seven days after receiving a third dose of the…
Author
Moderna to supply 12 million doses of Omicron-targetted COVID shot to Canada
The Canadian government had entered into a supply deal with the company last year for supply of its COVID vaccine for 2022 and…
Canada OKs Pfizer COVID booster for kids aged five-11 years
The authorisation for a booster shot was granted after a thorough, independent review of the vaccine, which "provides good…
US FDA orders Pfizer to test second Paxlovid course for rebound COVID patients
The drugmaker must produce initial results of a randomised controlled trial of a second course of the antiviral by 30th September…
WHO recommends use of two antibody drugs against Ebola
The drugs - Regeneron's Inmazeb and Ridgeback Bio's Ebanga- use laboratory-made monoclonal antibodies that mimic natural…
Novartis fails again to reuse anti-inflammatory drug to treat lung cancer
The failure in the latest trial, called Canopy A, is a setback for Novartis after canakinumab failed in two separate studies last…
UK first to approve Omicron COVID shot with Moderna nod
The UK medicines regulator (MHRA) approved the so-called bivalent vaccine made by Moderna as a booster for adults
Africa CDC hopeful Aspen will get COVID vaccine orders
Africa Centers for Disease Control and Prevention (CDC) said last month that it is in detailed discussions with buyers to generate…
US FDA authorises Bavarian Nordic’s Jynneos for emergency use against monkeypox
The authorisation will increase the total number of doses available for use by up to five-fold and also allows for use of the…
US FDA says possible carcinogen found in some Merck diabetes drugs
The agency said it would temporarily allow Merck to distribute drugs with sitagliptin containing a higher than normally acceptable…